Iranian Heart Journal

Iranian Heart Journal

A Case of Guillain–Barre Syndrome After Anterolateral Myocardial Infarction and Percutaneous Coronary Intervention for it

Document Type : Case Report

Authors
Farzad Emami 1
Mojtaba Khazaei 1
Hossein Foroughimoghaddam 2
Behshad Naghshtabrizi 2
Nima Naghshtabrizi 3
1 Hamedan University of Medical Science, Hamadan, IR Iran.
2 Department of Cardiology, Hamadan University of Medical Sciences, Hamadan, IR Iran.
3 Department of Cardiology, Tehran University of Medical Sciences, Tehran, IR Iran.
Abstract
A 44-year-old woman presenting with a typical history of acute coronary syndrome and anterolateral myocardial infarction in electrocardiography underwent primary percutaneous coronary intervention (PCI). After a few days, she complained of motor and sensory loss in her lower extremities. Given her symptoms, signs, and laboratory exams, Guillain–Barre syndrome (GBS) was diagnosed. Her management was done successfully with therapeutic plasma exchange. Acute myocardial infarction and subsequent PCI might be one of the most uncommon reasons for GBS. (Iranian Heart Journal 2022; 23(3): 120-125)
Keywords
Guillain-Barre syndrome
Myocardial infarction
Percutaneous coronary intervention
Plasma exchange
  1. van Doorn PA. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS). La Presse Médicale. 2013; 42(6):e193-e201.
  2. Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis. Neuroepidemiology. 2011; 36(2):123-33.
  3. Kundu AK. 6th ed. Kolkata: Kaustuv Paul for KSP Udyog; 2003. Bedside Clinics in Medicine; p. 160.
  4. Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014; 137(1):33-43.
  5. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, et al. Guidelines on the use of therapeutic apheresis in clinical practice—evidence‐based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher. 2010; 25(3):83-177.
  6. Kes P, Pasini J. Therapeutic plasma exchange in the critically ill patients. Acta Clin Croat. 1999;38(4):259-74.
  7. Thiele R, Jakob H, Hund E, Tantzky S, Keller S, Kamler M, et al. Sepsis and catecholamine support are the major risk factors for critical illness polyneuropathy after open heart surgery. The Thoracic and cardiovascular surgeon. 2000;48(03):145-50.
  8. Mateen FJ, van de Beek D, Kremers WK, Daly RC, Edwards BS, McGregor CG, et al. Neuromuscular diseases after cardiac transplantation. The Journal of heart and lung transplantation. 2009;28(3):226-30.
  9. Davidov N, Vinogradov O, Gorokhovatskiy Y, Kuznetsov A. Polyneuropathy in Patients Undergoing Cardiac Surgery. J Anesth Crit Care Open Access. 2017;9(2):00338.
Iranian Heart Journal
Volume 23, Issue 3
Summer 2022
Pages 120-125